{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:08:32Z","timestamp":1789884512449,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81422044"],"award-info":[{"award-number":["81422044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673362"],"award-info":[{"award-number":["81673362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.biomaterials.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T06:01:55Z","timestamp":1488866515000},"page":"8-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Engineering intravaginal vaccines to overcome mucosal and epithelial barriers"],"prefix":"10.1016","volume":"128","author":[{"given":"Zhonghua","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6831","key":"10.1016\/j.biomaterials.2017.03.007_bib1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/35073639","article-title":"The global impact of HIV\/AIDS","volume":"410","author":"Piot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib3","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","article-title":"Severe CD4+ t-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy","volume":"77","author":"Guadalupe","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jri.2007.01.006","article-title":"Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites","volume":"73","author":"Mestecky","year":"2007","journal-title":"J.\u00a0Reprod. Immunol."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd4364","article-title":"The HIV pipeline","volume":"13","author":"Wong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.4449","article-title":"HIV and the spectrum of human disease","volume":"235","author":"Lucas","year":"2015","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12249-008-9073-5","article-title":"A\u00a0review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV\/AIDS and prevention of sexually transmitted infections","volume":"9","author":"Ndesendo","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib8","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1016\/j.vaccine.2010.04.018","article-title":"Mucosal HIV vaccines. a holy grail or a dud?","volume":"28","author":"Azizi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2014.03.018","article-title":"Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines","volume":"183","author":"Klein","year":"2014","journal-title":"J.\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2017.03.007_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","article-title":"Adenoviral vectors for mucosal vaccination against infectious diseases","volume":"18","author":"Santosuosso","year":"2005","journal-title":"Viral Immunol."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib12","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex\u00a0vivo and distribution in\u00a0vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2014.07.045","article-title":"Nanoparticle penetration of human cervicovaginal mucus. The effect of polyvinyl alcohol","volume":"192","author":"Ming Yang","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/BSR20080023","article-title":"Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells","volume":"29","author":"Liu","year":"2009","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2015.02.050","article-title":"Mucosal vaccination by adenoviruses displaying reovirus sigma 1","volume":"482","author":"Weaver","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib18","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1021\/bm501419z","article-title":"Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus","volume":"15","author":"Ensign","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib19","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1016\/j.biomaterials.2014.05.056","article-title":"Adenoviral vectors coated with cationic PEG derivatives for intravaginal vaccination against HIV-1","volume":"35","author":"Xie","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib20","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib21","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jps.23556","article-title":"Evaluation of cell-penetrating peptide\/adenovirus particles for transduction of CAR-negative cells","volume":"102","author":"Nigatu","year":"2013","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2015.02.015","article-title":"Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus","volume":"71","author":"Nigatu","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.peptides.2009.05.017","article-title":"Transduction of adenovirus vectors modified with cell-penetrating peptides","volume":"30","author":"Eto","year":"2009","journal-title":"Peptides"},{"issue":"Pt A","key":"10.1016\/j.biomaterials.2017.03.007_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejpb.2013.09.016","article-title":"PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease","volume":"85","author":"Lautenschl\u00e4ger","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib27","series-title":"Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy","author":"Sande","year":"1999"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/aid.2011.0071","article-title":"A\u00a0comparison of lower genital tract glycogen and lactic acid levels in women and macaques: implications for HIV and SIV susceptibility","volume":"28","author":"Mirmonsef","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib29","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.03.007_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/hum.2015.153","article-title":"Prime-boost strategy combining intravaginal and intramuscular administration of homologous adenovirus to enhance immune response against HIV-1 in mice","volume":"27","author":"Ji","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2017.03.007_bib31","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib32","doi-asserted-by":"crossref","first-page":"28912","DOI":"10.3390\/ijms161226142","article-title":"Cell penetrating peptide conjugated chitosan for enhanced delivery of nucleic acid","volume":"16","author":"Layek","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib33","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1038\/nm1216","article-title":"Can successful vaccines teach us how to induce efficient protective immune responses?","volume":"11","author":"Lambert","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.03.007_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2006.07.011","article-title":"Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus","volume":"25","author":"de Souza","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biomaterials.2017.03.007_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1471-4914(02)02401-2","article-title":"A\u00a0new generation of HIV vaccines","volume":"8","author":"Amara","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.03.007_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/smim.1997.0086","article-title":"Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract","volume":"9","author":"Rosenthal","year":"1997","journal-title":"Semin. Immunol."},{"issue":"1\u20136","key":"10.1016\/j.biomaterials.2017.03.007_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1699-0463.1995.tb01101.x","article-title":"IgA and mucosal defense","volume":"103","author":"Lamm","year":"1995","journal-title":"Apmis"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121730145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121730145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:24:03Z","timestamp":1758903843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121730145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":37,"alternative-id":["S014296121730145X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.007","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering intravaginal vaccines to overcome mucosal and epithelial barriers","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}